These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 32437925)
1. Quantitative features and clinical significance of two subpopulations of AChR-specific CD4+ T cells in patients with myasthenia gravis. Liu X; Ma Q; Qiu L; Ou C; Lin Z; Lu Y; Huang H; Chen P; Huang Z; Liu W Clin Immunol; 2020 Jul; 216():108462. PubMed ID: 32437925 [TBL] [Abstract][Full Text] [Related]
2. CD4 Çebi M; Durmus H; Aysal F; Özkan B; Gül GE; Çakar A; Hocaoglu M; Mercan M; Yentür SP; Tütüncü M; Yayla V; Akan O; Dogan Ö; Parman Y; Saruhan-Direskeneli G Front Immunol; 2020; 11():809. PubMed ID: 32508812 [TBL] [Abstract][Full Text] [Related]
3. Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK. Yilmaz V; Oflazer P; Aysal F; Durmus H; Poulas K; Yentur SP; Gulsen-Parman Y; Tzartos S; Marx A; Tuzun E; Deymeer F; Saruhan-Direskeneli G PLoS One; 2015; 10(4):e0123546. PubMed ID: 25893403 [TBL] [Abstract][Full Text] [Related]
4. Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody positive myasthenia gravis patients. Li Y; Guptill JT; Russo MA; Massey JM; Juel VC; Hobson-Webb LD; Howard JF; Chopra M; Liu W; Yi JS Exp Neurol; 2019 Feb; 312():43-50. PubMed ID: 30472069 [TBL] [Abstract][Full Text] [Related]
5. High frequencies of circulating Tfh-Th17 cells in myasthenia gravis patients. Yang Y; Zhang M; Ye Y; Ma S; Fan L; Li Z Neurol Sci; 2017 Sep; 38(9):1599-1608. PubMed ID: 28578482 [TBL] [Abstract][Full Text] [Related]
7. Circulating Th1/17 cells serve as a biomarker of disease severity and a target for early intervention in AChR-MG patients. Ma Q; Ran H; Li Y; Lu Y; Liu X; Huang H; Yang W; Yu L; Chen P; Huang X; Qiu L; Lin Z; Ou C; Liu W Clin Immunol; 2020 Sep; 218():108492. PubMed ID: 32526271 [TBL] [Abstract][Full Text] [Related]
8. [Identification of correlations between numbers of CD4+ CD25+ Treg cells, levels of sera anti-AChR antibodies and transfer growth factor-beta in patients with myasthenia gravis]. Wang HB; Zhang JB; Chui LY Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1036-40. PubMed ID: 18754436 [TBL] [Abstract][Full Text] [Related]
9. Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis. Berrih S; Morel E; Gaud C; Raimond F; Le Brigand H; Bach JF Neurology; 1984 Jan; 34(1):66-71. PubMed ID: 6228745 [TBL] [Abstract][Full Text] [Related]
11. Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody. Moulian N; Bidault J; Truffault F; Yamamoto AM; Levasseur P; Berrih-Aknin S Blood; 1997 May; 89(9):3287-95. PubMed ID: 9129034 [TBL] [Abstract][Full Text] [Related]
12. T cell recognition of muscle acetylcholine receptor in ocular myasthenia gravis. Wang ZY; Diethelm-Okita B; Okita DK; Kaminski HJ; Howard JF; Conti-Fine BM J Neuroimmunol; 2000 Aug; 108(1-2):29-39. PubMed ID: 10900334 [TBL] [Abstract][Full Text] [Related]
13. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes. Ofosu-Appiah W; Mokhtarian F; Shirazian D; Grob D J Lab Clin Med; 1994 Aug; 124(2):231-41. PubMed ID: 8051487 [TBL] [Abstract][Full Text] [Related]
14. T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis. Wang ZY; Okita DK; Howard J; Conti-Fine BM Neurology; 1998 Apr; 50(4):1045-54. PubMed ID: 9566393 [TBL] [Abstract][Full Text] [Related]
15. Th1 epitope repertoire on the alpha subunit of human muscle acetylcholine receptor in myasthenia gravis. Wang ZY; Okita DK; Howard J; Conti-Fine BM Neurology; 1997 Jun; 48(6):1643-53. PubMed ID: 9191781 [TBL] [Abstract][Full Text] [Related]